Upload Avatar (500 x 500)
Hong Pan
hong.pan@siat.ac.cn
Chinese, English
Guangdong
University of Chinese Academy of Sciences
Life Sciences
  • 2015-09--2019-01 PhD: University of Chinese Academy of Sciences
  • 2008-09--2011-07 Master's: Sun Yat-sen University
  • 2004-09--2008-07 Bachelor's: Hunan University of Science and Technology
  • 2020-01~Present - Shenzhen Institutes of Advanced Technology - Associate Researcher
  • 2011-06~2019-12 - Shenzhen Institutes of Advanced Technology - Research Assistant/Assistant Researcher
  • Shenzhen Natural Science First Prize (2020): First Prize
  • Guangdong Science and Technology Second Prize (2016): Second Prize
Live Cell Drugs
Cell Therapy
Nanomedicine
Tumor Nanoimmunology
Click Chemistry
Micro/Nano Bio-Robots
  • Oxygen Self-supplying Small Size Magnetic Nanoenzymes for Synergistic Photodynamic and Catalytic Therapy of Breast Cancer, Hong Pan, 2024
  • T cell Cascade regulation Initiates Systemic Antitumor Immunity Through Living Drug Factory of Anti-PD-1/IL-12 Engineered Probiotics, Hong Pan, 2024
  • Platelet-based Bioactive Systems Guided Precision Targeting and Immune Regulation for Cancer Therapy, Hong Pan, 2024
  • Bioactive materials programed CAR-T cell living drug for augmented immunotherapy against tumors, Hong Pan, 2024
  • Twin-bioengine self-adaptive micro/nanorobots employing enzyme actuation and macrophage relay for gastrointestinal inflammation therapy, Hong Pan, 2023
  • Magnetic–acoustic sequentially actuated CAR T cell microrobots for precision navigation and in situ antitumor immunoactivation, Hong Pan, 2023
  • Cell-based intelligent micro/nanorobots for precise regulation and active bio-therapy, Hong Pan, 2023
  • Biocompatible smart micro/nanorobots for active gastrointestinal tract drug delivery, Hong Pan, 2023
  • Cell surface-nanoengineering for cancer targeting immunoregulation and precise immunotherapy, Hong Pan, 2022
  • Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy, Hong Pan, 2022
  • Cell/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy, Hong Pan, 2021
  • Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor, Hong Pan, 2021
  • Sequential Magneto-Actuated and Optics-Triggered Biomicrorobots for Targeted Cancer Therapy, Hong Pan, 2021
  • In situ poly I:C released from living cell drug nanocarriers for macrophage-mediated antitumor immunotherapy, Hong Pan, 2021
  • Nanoengineered CAR-T Biohybrids for Solid Tumor Immunotherapy with Microenvironment Photothermal-Remodeling Strategy, Hong Pan, 2021
  • In Situ Photocatalysis of TiO-Porphyrin-Encapsulated Nanosystem for Highly Efficient Oxidative Damage against Hypoxic Tumors, Hong Pan, 2020
  • In Situ Photocatalyzed Oxygen Generation with Photosynthetic Bacteria to Enable Robust Immunogenic Photodynamic Therapy in Triple-Negative Breast Cancer, Hong Pan, 2020
  • Advances in Bioorthogonal Chemistry for in vivo Labeling and Drug Delivery, Hong Pan, 2020
  • Up-regulation of miR-27a promotes monocyte-mediated inflammatory responses in Kawasaki disease by inhibiting function of B10 cells, Hong Pan, 2020
  • Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer, Hong Pan, 2020
  • Bioorthogonal Metabolic Labeling Utilizing Protein Biosynthesis for Dynamic Visualization of Nonenveloped Enterovirus 71 Infection, Hong Pan, 2020
  • Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice, Hong Pan, 2020
  • Smart gold nanocages for mild heat-triggered drug release and breaking chemoresistance, Hong Pan, 2020
  • T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy, Hong Pan, 2019
  • 基于代谢工程与生物正交反应的病毒原位标记技术研究, Hong Pan, 2019
  • 2016—2017年深圳地区柯萨奇病毒A16型分子特征分析, Hong Pan, 2019
  • Bio-Orthogonal T Cell Targeting Strategy for Robustly Enhancing Cytotoxicity against Tumor Cells, Hong Pan, 2019
  • Glycometabolic Bioorthogonal Chemistry-Guided Viral Transduction for Robust Human T Cell Engineering, Hong Pan, 2019
  • Ros-inducing micelles sensitize tumor-associated macrophages to tlr3 stimulation for potent immunotherapy, Hong Pan, 2018
  • Dissecting complicated viral spreading of enterovirus 71 using in situ bioorthogonal fluorescent labeling, Hong Pan, 2018
  • Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy, Hong Pan, 2017
  • In Situ Bioorthogonal Metabolic Labeling for Fluorescence Imaging of Virus Infection In Vivo., Hong Pan, 2017
  • Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy, Hong Pan, 2016
  • Retinal-conjugated pH-sensitive micelles induce tumor senescence for boosting breast cancer chemotherapy, Hong Pan, 2016
  • QDs-virus bioconjugate as potential gene-drug co-delivery system for synergistic tumor therapy, Hong Pan, 2016
  • Self-adjuvanted nanovaccine for cancer immunotherapy: Role of lysosomal rupture-induced ROS in MHC class I antigen presentation, Hong Pan, 2016
  • Bioorthogonal multifunctional nanoprobes for biomedicine and theranostic applications, Hong Pan, 2016
  • Synergistic Therapy of Doxorubicin and miR-129-5p with Self-Cross-Linked Bioreducible Polypeptide Nanoparticles Reverses Multidrug Resistance in Cancer Cells, Hong Pan, 2016
  • Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis, Hong Pan, 2016
  • Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy, Hong Pan, 2016
  • Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory, Hong Pan, 2015
  • Doxorubicin-loaded pH-sensitive dextran-retinal nanoparticles suppress tumor growth by inducing both apoptosis and cell senescence, Hong Pan, 2015
  • Co-delivery of poly I:C and STAT3 siRNA by nanovaccines effectively overcomes tumor-associated dendritic cell dysfunction and elicits anti-tumor immune response, Hong Pan, 2015
  • Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells invivo, Hong Pan, 2015
  • Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-kappa B and p38 MAPK signaling pathways, Hong Pan, 2014
  • Noninvasive Visualization of Respiratory Viral Infection Using Bioorthogonal Conjugated Near-Infrared-Emitting Quantum Dots, Hong Pan, 2014
  • Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory, Hong Pan, 2014
  • Functionalized quantum dots induce proinflammatory responses in vitro: the role of terminal functional group-associated endocytic pathways, Hong Pan, 2013
  • Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses, Hong Pan, 2013
  • Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3–IRF3 signaling and type I interferons in dendritic cells, Hong Pan, 2012
Live Cell Drugs Cell Therapy Nanomedicine Tumor Nanoimmunology Click Chemistry Micro/Nano Bio-Robots Cancer Immunotherapy Biomaterials Drug Delivery

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.